Neuroendocrine Mechanisms of Developmental Massage Therapy (DMT) in

Status Completed

Clinical Trial Summary

The purpose of this study is to see if daily massage therapy will help premature infants respond to stress better, as well as improve their growth and neurobehavioral development.

Clinical Trial Description

Optimal postnatal growth and development is essential for the survival and long-term health of infants born premature, however, growth and developmental delays are common. Many factors contribute to poor postnatal growth and development including immature organ systems, stress due to illness and even routine care in the neonatal intensive care unit environment. Massage therapy is associated with decreased cortisol levels during stress in a variety of populations including premature infants. Massage has also been reported to improve postnatal weight gain in premature infants. Concerns about methodological quality, however, weaken the credibility of previous studies and prevent the integration of massage therapy into conventional medical practice. Therefore, we plan to study the interrelationship of the ANS and HPA axis in preterm infants to assess how developmental massage therapy (DMT) modulates physiologic stability and promotes postnatal growth by the following specific aims:

SPECIFIC AIM 1: We will determine ANS balance, measured by heart period variability, before, during, and after DMT.

SPECIFIC AIM 2: We will compare the relationships between ANS balance and HPA response before and after DMT.

SPECIFIC AIM 3: We will evaluate somatotrophic response in premature infants who receive DMT.

Infants will be stratified by gender and randomized to receive developmental massage therapy or SHAM control.

This study will also allow for post-discharge assessment of development. Infants will return to the hospital at term, 3months and 6 months for multiple measurements and developmental testing. ;

Study Design

Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver), Primary Purpose: Basic Science

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT00722943
Study type	Interventional
Source	University of Utah
Contact
Status	Completed
Phase	N/A
Start date	July 2008
Completion date	July 2011

View Details

See also
Status	Clinical Trial	Phase
Active, not recruiting	`NCT02452580` - The Norwegian Family Centered Care Study
Completed	`NCT02502916` - Enteral Feeding and Early Gut Colonization of Preterm Infants	N/A
Completed	`NCT01748214` - Premature Infant Exposure to Noise Generated by Respiratory Support	N/A
Terminated	`NCT02840825` - Biochip for HCMV Detection in Breast Milk
Recruiting	`NCT02306317` - The Adding Value of Parents to Nursing Care in the Control of FiO2	N/A
Completed	`NCT01354028` - Effects of Massage Therapy to Induce Sleep in Preterm Infants	N/A
Completed	`NCT01881256` - The BabyGrow Longitudinal Study of Nutrition and Growth in Preterm Infants	N/A
Completed	`NCT03001479` - Noninferiority Trial of Liquid Human Milk Fortifier (HMF) Hydrolyzed Protein Versus Liquid HMF With Supplemental Liquid Protein	N/A
Completed	`NCT02788786` - Feasibility and Acceptability of Use of Daily Oral Rinse in Pregnant Women in Rural Nepal	Phase 2
Completed	`NCT01678638` - Timing of Inguinal Hernia Repair in Premature Infants	N/A
Recruiting	`NCT02623400` - The Effect of Perinatal Stress on the Development of Preterm Infants
Completed	`NCT02523222` - Prophylactic Dextrose Gel for Newborns at High-risk for Hypoglycemia	N/A
Active, not recruiting	`NCT02508571` - Direct Swallowing Training and Oral Sensorimotor Stimulation in Preterm Infants	N/A
Completed	`NCT02478684` - Delayed Cord Clamping in Preterm Neonates	N/A
Completed	`NCT02477423` - A Randomized Controlled Trial Investigating if Antibiotic Use in the First 48 Hours of Life Adversely Impacts the Preterm Infant Microbiome	N/A
Terminated	`NCT02040909` - Optimizing Propofol Dosing for (Preterm) Newborn Infants That Need Endotracheal Intubation	Phase 1
Active, not recruiting	`NCT02832011` - How Effect Olive Oil and Eoprotin on Immunological Parameters and Growth	N/A
Completed	`NCT02643472` - GPS (Giving Parents Support): Parent Navigation After NICU Discharge	N/A
Terminated	`NCT01759134` - Comparison of Post-Discharge Growth of Premature Infants Using Two Different Formulas	Phase 4
Completed	`NCT01628510` - The Developmental Effects of NICU Positioning	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Neuroendocrine Mechanisms of Developmental Massage Therapy (DMT) in Preterm Infants: Clinical Study — DMT

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms